Published in Acta Derm Venereol on July 01, 2014
Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe. Eur J Health Econ (2016) 0.75
The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol (2008) 3.72
Bullous pemphigoid as pruritus in the elderly: a common presentation. JAMA Dermatol (2013) 2.61
Estimating dopamine D₂ receptor occupancy for doses of 8 antipsychotics: a meta-analysis. J Clin Psychopharmacol (2013) 2.07
Reliability and convergent validity of two outcome instruments for pemphigus. J Invest Dermatol (2009) 1.88
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol (2008) 1.81
Recalcitrant cutaneous warts treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, and 18) in a developmentally delayed, 31-year-old white man. Arch Dermatol (2010) 1.77
The international dystrophic epidermolysis bullosa patient registry: an online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations. Hum Mutat (2011) 1.65
Interventions for pemphigus vulgaris and pemphigus foliaceus. Cochrane Database Syst Rev (2009) 1.59
Trichostasis spinulosa: itchy follicular papules in young adults. Int J Dermatol (2002) 1.51
IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. J Am Acad Dermatol (2002) 1.50
Increased expression of integrin α6β4 in the basement membrane zone lining the sebaceous glands in hidradenitis suppurativa. Acta Derm Venereol (2015) 1.47
Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations. J Invest Dermatol (2012) 1.45
Keratin 14-null cells as a model to test the efficacy of gene therapy approaches in epithelial cells. J Invest Dermatol (2011) 1.44
Risk of squamous cell carcinoma in junctional epidermolysis bullosa, non-Herlitz type: report of 7 cases and a review of the literature. J Am Acad Dermatol (2011) 1.43
Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy (2012) 1.41
Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis. Acta Derm Venereol (2007) 1.39
Pigmentation and melanocyte supply to the epidermis depend on type XVII collagen. Exp Dermatol (2014) 1.39
Dilated cardiomyopathy in epidermolysis bullosa: a retrospective, multicenter study. Pediatr Dermatol (2010) 1.39
Minor neurological dysfunction and behaviour in 9-year-old children born at term: evidence for sex dimorphism. Dev Med Child Neurol (2013) 1.38
The histopathological spectrum of acute generalized exanthematous pustulosis (AGEP) and its differentiation from generalized pustular psoriasis. J Cutan Pathol (2010) 1.36
Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3. J Clin Invest (2007) 1.17
Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Müllerian hormone null mice. Endocrinology (2007) 1.15
Enamel defects in carriers of a novel LAMA3 mutation underlying epidermolysis bullosa. Acta Derm Venereol (2012) 1.11
Retrospective diagnosis of fatal BP180-deficient non-Herlitz junctional epidermolysis bullosa suggested by immunofluorescence (IF) antigen-mapping of parental carriers bearing enamel defects. J Invest Dermatol (2007) 1.10
Punctate pemphigus: an underreported direct immunofluorescence pattern. J Cutan Pathol (2014) 1.09
Interventions for bullous pemphigoid. Cochrane Database Syst Rev (2010) 1.09
Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa. Cancer Res (2012) 1.07
Diffuse melanosis cutis: a systematic review of the literature. J Am Acad Dermatol (2012) 1.06
A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol (2013) 1.05
Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol (2011) 1.04
Narrow band imaging is a new technique in visualization of recurrent respiratory papillomatosis. Laryngoscope (2012) 1.04
Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis. Arthritis Rheum (2006) 1.03
Revertant mosaicism--patchwork in the skin. N Engl J Med (2009) 1.03
NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors. Radiother Oncol (2012) 1.03
Multiple correcting COL17A1 mutations in patients with revertant mosaicism of epidermolysis bullosa. Am J Hum Genet (2005) 1.02
Probiotics for treating eczema. Cochrane Database Syst Rev (2008) 1.00
Basement membrane reconstruction in human skin equivalents is regulated by fibroblasts and/or exogenously activated keratinocytes. J Invest Dermatol (2005) 1.00
Main problems experienced by children with epidermolysis bullosa: a qualitative study with semi-structured interviews. Acta Derm Venereol (2008) 1.00
Skin problems of the stump in lower limb amputees: 1. A clinical study. Acta Derm Venereol (2011) 0.98
Deficiency of ATP2C1, a Golgi ion pump, induces secretory pathway defects in endoplasmic reticulum (ER)-associated degradation and sensitivity to ER stress. J Biol Chem (2004) 0.96
Partial revertant mosaicism of keratin 14 in a patient with recessive epidermolysis bullosa simplex. J Invest Dermatol (2002) 0.96
Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies. Int J Dermatol (2009) 0.96
Type XVII collagen regulates lamellipod stability, cell motility, and signaling to Rac1 by targeting bullous pemphigoid antigen 1e to alpha6beta4 integrin. J Biol Chem (2011) 0.93
Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus? Arthritis Res Ther (2006) 0.93
Quality-of-life measurement in blistering diseases. Dermatol Clin (2011) 0.92
Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injury. J Pathol (2012) 0.91
Complete resolution of chronic multiple verruca vulgaris treated with quadrivalent human papillomavirus vaccine. JAMA Dermatol (2013) 0.91
External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy. Radiother Oncol (2011) 0.91
Staphylococcal scalded skin syndrome: loss of desmoglein 1 in patient skin. Eur J Dermatol (2010) 0.91
Skin and heart: une liaison dangereuse. Exp Dermatol (2009) 0.90
Development of a quality-of-life instrument for autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life questionnaire. JAMA Dermatol (2013) 0.90
The effect of a clinical pharmacist-led training programme on intravenous medication errors: a controlled before and after study. BMJ Qual Saf (2013) 0.90
Revertant mosaicism in heritable skin diseases: mechanisms of natural gene therapy. Discov Med (2012) 0.90
Differential expression of pyloric atresia in junctional epidermolysis bullosa with ITGB4 mutations suggests that pyloric atresia is due to factors other than the mutations and not predictive of a poor outcome: three novel mutations and a review of the literature. Acta Derm Venereol (2008) 0.89
Revertant mosaicism due to a second-site mutation in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa. J Invest Dermatol (2010) 0.89
Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita. J Am Acad Dermatol (2012) 0.89
High genetic diversity of Staphylococcus aureus strains colonizing patients with epidermolysis bullosa. Exp Dermatol (2012) 0.89
Enhanced diagnostic immunofluorescence using biopsies transported in saline. BMC Dermatol (2004) 0.88
High anti-staphylococcal antibody titers in patients with epidermolysis bullosa relate to long-term colonization with alternating types of Staphylococcus aureus. J Invest Dermatol (2012) 0.88
Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra induction. J Autoimmun (2012) 0.87
Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisita. J Pathol (2011) 0.87
PLEC1 mutations underlie adult-onset dilated cardiomyopathy in epidermolysis bullosa simplex with muscular dystrophy. J Invest Dermatol (2009) 0.87
A systematic review and meta-analysis on the prevalence of Dupuytren disease in the general population of Western countries. Plast Reconstr Surg (2014) 0.86
Population-specific association between a polymorphic variant in ST18, encoding a pro-apoptotic molecule, and pemphigus vulgaris. J Invest Dermatol (2012) 0.86
Skin problems of the stump in lower-limb amputees: 2. Influence on functioning in daily life. Acta Derm Venereol (2011) 0.86
Epidemiology of epidermolysis bullosa in the antipodes: the Australasian Epidermolysis Bullosa Registry with a focus on Herlitz junctional epidermolysis bullosa. Arch Dermatol (2010) 0.85
Skin problems in lower limb amputees: a systematic review. Disabil Rehabil (2006) 0.85
Immunoadsorption against two distinct epitopes on human type XVII collagen abolishes dermal-epidermal separation induced in vitro by autoantibodies from pemphigoid gestationis patients. Eur J Immunol (2006) 0.85
Revertant mosaicism in a human skin fragility disorder results from slipped mispairing and mitotic recombination. J Clin Invest (2012) 0.85
Natural gene therapy in dystrophic epidermolysis bullosa. Arch Dermatol (2011) 0.85
Contamination rates of three urine-sampling methods to assess bacteriuria in pregnant women. Obstet Gynecol (2013) 0.83
Experimental human cell and tissue models of pemphigus. Dermatol Res Pract (2010) 0.83
Determinants of skin problems of the stump in lower-limb amputees. Arch Phys Med Rehabil (2009) 0.83
Transition of pemphigus vulgaris into pemphigus foliaceus confirmed by antidesmoglein ELISA profile. Int J Dermatol (2002) 0.83
Topically applied flightless I neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisita. J Invest Dermatol (2012) 0.83
Prevalence of Dupuytren disease in The Netherlands. Plast Reconstr Surg (2013) 0.83
Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial. Arch Dermatol (2006) 0.83
The main problems of parents of a child with epidermolysis bullosa. Qual Health Res (2008) 0.83
First symposium on natural gene therapy of the skin. Exp Dermatol (2012) 0.82
Pigmentary mosaicism following the lines of Blaschko in a girl with a double aneuploidy mosaicism: (47,XX,+7/45,X). Am J Med Genet A (2005) 0.82
Plaque-like cutaneous mucinosis: case report and literature review. Am J Dermatopathol (2012) 0.81
Lethal acantholytic epidermolysis bullosa. Dermatol Clin (2010) 0.81
Bacterial adhesion forces with substratum surfaces and the susceptibility of biofilms to antibiotics. Antimicrob Agents Chemother (2012) 0.81
Topography of distinct Staphylococcus aureus types in chronic wounds of patients with epidermolysis bullosa. PLoS One (2013) 0.81
Subtherapeutic Posaconazole Exposure and Treatment Outcome in Patients With Invasive Fungal Disease. Ther Drug Monit (2015) 0.80
Blistering disease: insight from the hemidesmosome and other components of the dermal-epidermal junction. Cell Tissue Res (2014) 0.80
The inversa type of recessive dystrophic epidermolysis bullosa is caused by specific arginine and glycine substitutions in type VII collagen. J Med Genet (2010) 0.80
Treatment of pemphigus: the need for more evidence. Arch Dermatol (2008) 0.79
Mutation analysis of the entire keratin 5 and 14 genes in patients with epidermolysis bullosa simplex and identification of novel mutations. Hum Mutat (2003) 0.79
Hereditary multiple cutaneous leiomyoma resulting from novel mutations in the fumarate hydratase gene. J Dermatol Sci (2008) 0.79
Patterns of Dupuytren disease in fingers: studying correlations with a multivariate ordinal logit model. Plast Reconstr Surg (2014) 0.78
Extensive acantholysis as the major histological feature of a severe case of Dowling Meara-epidermolysis bullosa simplex: a reappraisal of acantholysis in the newborn. Eur J Dermatol (2012) 0.78
Surgical treatment of sinuses by deroofing in hidradenitis suppurativa. Dermatol Surg (2011) 0.78
The Reliability, Validity and Responsiveness of Two Disease Scores (BPDAI and ABSIS) for Bullous Pemphigoid: Which One to Use? Acta Derm Venereol (2017) 0.78
The IgG "lupus-band" deposition pattern of pemphigus erythematosus: association with the desmoglein 1 ectodomain as revealed by 3 cases. Arch Dermatol (2012) 0.78
Successful single-cycle rituximab treatment in a patient with pemphigus vulgaris and squamous cell carcinoma of the tongue and IgG antibodies to desmocollins. J Am Acad Dermatol (2013) 0.78